In vitro comparative antimicrobial activity of cefpimizole against clinical isolates from five medical centers
Open Access
- 1 June 1985
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 27 (6) , 982-984
- https://doi.org/10.1128/aac.27.6.982
Abstract
Cefpimizole was compared with cefoperazone and cefotaxime against 6,599 clinical bacterial isolates from five medical centers. Cefoperazone and cefotaxime were both more active and provided a greater spectrum of antimicrobial coverage than cefpimizole. Some of the cefpimizole minimum concentrations inhibiting 50% of tested strains were as follows: Citrobacter freundii and Enterobacter cloacae, 16 micrograms/ml; Escherichia coli and Klebsiella pneumoniae, 2.0 micrograms/ml; Proteus mirabilis, 1.0 microgram/ml; Pseudomonas aeruginosa, 16 micrograms/ml; Staphylococcus spp., 32 micrograms/ml; and the enterococci, greater than 32 micrograms/ml.Keywords
This publication has 8 references indexed in Scilit:
- In vitro antimicrobial susceptibility testing using 30 μG and 75 μG U63196-E (cefpimizole AC-1370) disksDiagnostic Microbiology and Infectious Disease, 1985
- Pharmacokinetics of cefpimizole in normal humans after single- and multiple-dose intravenous infusionsAntimicrobial Agents and Chemotherapy, 1984
- In vitro evaluation of U63196-E (AC-1370): Antimicrobial activity, β-lactamase stability, and β-lactamase inhibitionDiagnostic Microbiology and Infectious Disease, 1984
- In vitro activity and beta-lactamase stability of U-63196E, a novel cephalosporinAntimicrobial Agents and Chemotherapy, 1983
- Effects of AC-1370, a new semisynthetic cephalosporin, on phagocyte functionsAntimicrobial Agents and Chemotherapy, 1983
- Synthesis and antibacterial activity of 6- and 7- (2-(5-carboxyimidazole-4-carboxamido)phenylacetamido)-penicillins and cephalosporins.The Journal of Antibiotics, 1983
- Infectious Diseases of the Thyroid GlandClinical Infectious Diseases, 1983
- Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporinsAntimicrobial Agents and Chemotherapy, 1982